Literature DB >> 2091334

The pharmacokinetic properties of intramuscular quinine in Gambian children with severe falciparum malaria.

D Waller1, S Krishna, C Craddock, D Brewster, A Jammeh, D Kwiatkowski, J Karbwang, P Molunto, N J White.   

Abstract

Plasma quinine concentrations were measured in 21 Gambian children with severe falciparum malaria after intramuscular administration of a 20 mg (salt) per kg loading dose of quinine dihydrochloride followed by 10 mg/kg at 12 h intervals. Quinine was well absorbed reaching mean peak concentrations of 15.6 (standard deviation [SD] 4.5) mg/litre in a median time of 3 h (range 1-6 h). A one compartment model was fitted to the plasma concentration-time profile. The mean estimated systemic clearance (Cl/F) was 0.89 (SD 0.81) ml/kg/min and the mean elimination half life was 18.8 (SD 8.0) h. Two patients, one of whom died, had low plasma quinine levels which remained below 10 mg/litre. Mean peak and trough plasma concentrations after subsequent intramuscular doses ranged between 11.1 and 15.1 mg/litre. In most cases this dose regimen provided a satisfactory profile of blood concentrations for the treatment of severe malaria in children.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2091334     DOI: 10.1016/0035-9203(90)90009-4

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  10 in total

1.  Population pharmacokinetics of intramuscular quinine in children with severe malaria.

Authors:  S Krishna; N V Nagaraja; T Planche; T Agbenyega; G Bedo-Addo; D Ansong; A Owusu-Ofori; A L Shroads; G Henderson; A Hutson; H Derendorf; P W Stacpoole
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 2.  Antimalarial pharmacokinetics and treatment regimens.

Authors:  N J White
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

Review 3.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

4.  Absorption of intramuscular phenobarbitone in children with severe falciparum malaria.

Authors:  F Kuile; F Nosten; T Chongsuphajaisiddhi; P Holloway; L Maelankirri; N J White
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 5.  Management of severe malaria.

Authors:  Tanu Singhal
Journal:  Indian J Pediatr       Date:  2004-01       Impact factor: 1.967

Review 6.  High first dose quinine regimen for treating severe malaria.

Authors:  A Lesi; M Meremikwu
Journal:  Cochrane Database Syst Rev       Date:  2004

7.  Disposition of quinine in rats with induced renal failure.

Authors:  C O Onyeji; P A Dixon; N C Ugwu
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

8.  Population pharmacokinetic and pharmacodynamic properties of intramuscular quinine in Tanzanian children with severe Falciparum malaria.

Authors:  Ilse C E Hendriksen; Deogratius Maiga; Martha M Lemnge; George Mtove; Samwel Gesase; Hugh Reyburn; Niklas Lindegardh; Nicholas P J Day; Lorenz von Seidlein; Arjen M Dondorp; Joel Tarning; Nicholas J White
Journal:  Antimicrob Agents Chemother       Date:  2012-11-26       Impact factor: 5.191

Review 9.  Treatment of African children with severe malaria - towards evidence-informed clinical practice using GRADE.

Authors:  Nyokabi Musila; Newton Opiyo; Mike English
Journal:  Malar J       Date:  2011-07-21       Impact factor: 2.979

10.  Clinical pharmacokinetics of quinine and its relationship with treatment outcomes in children, pregnant women, and elderly patients, with uncomplicated and complicated malaria: a systematic review.

Authors:  Teerachat Saeheng; Kesara Na-Bangchang
Journal:  Malar J       Date:  2022-02-10       Impact factor: 2.979

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.